Anti-UFSP2 抗体 [EPR13424]
Anti-UFSP2 antibody [EPR13424]
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal UFSP2 antibody. Suitable for IP, WB, ICC/IF, IHC-P and reacts with Human samples. Cited in 5 publications.
別名を表示する
C4orf20, UFSP2, Ufm1-specific protease 2, UfSP2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UFSP2 antibody [EPR13424] (AB185965)
Immunohistochemical analysis of paraffin-embedded Human stomach tissue labeling UFSP2 with ab185965 at 1/100 dilution followed by pre-diluted HRP-conjugated secondary antibody and counter-stained with Hematoxylin.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UFSP2 antibody [EPR13424] (AB185965)
Immunohistochemical analysis of paraffin-embedded Human kidney clear cell carcinoma tissue labeling UFSP2 with ab185965 at 1/100 dilution followed by pre-diluted HRP-conjugated secondary antibody and counter-stained with Hematoxylin.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-UFSP2 antibody [EPR13424] (AB185965)
All lanes:
Western blot - Anti-UFSP2 antibody [EPR13424] (ab185965) at 1/10000 dilution
Lane 1:
Human fetal kidney lysate at 20 µg
Lane 2:
Human fetal heart lysate at 20 µg
Lane 3:
Human pancreas lysate at 20 µg
Lane 4:
HeLa cell lysate at 20 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 53 kDa
false
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-UFSP2 antibody [EPR13424] (AB185965)
Immunofluorescent analysis of HeLa cells (-20℃ acetone-fixed) labeling UFSP2 with ab185965 at 1/100 dilution follwed by Goat anti rabbit IgG (AlexaFluor® 555) secondary at 1/200 dilution and counter-stained with DAPI (blue).
- IP
Supplier Data
Immunoprecipitation - Anti-UFSP2 antibody [EPR13424] (AB185965)
Western blot analysis of immunoprecipitation pellet from Human fetal kidney lysate immunoprecipitated using ab185965 at 1/50 dilution (lane 1) or PBS control (lane 2).
Secondary : Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 dilution.
All lanes:
Immunoprecipitation - Anti-UFSP2 antibody [EPR13424] (ab185965)
Predicted band size: 53 kDa
false
- WB
Lab
Western blot - Anti-UFSP2 antibody [EPR13424] (AB185965)
Lanes 1-3 : Merged signal (red and green). Green - ab185965 observed at 53 kDa. Red - loading control ab8245 observed at 36 kDa.
ab185965 Anti-UFSP2 antibody [EPR13424] was shown to specifically react with UFSP2 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266368 (knockout cell lysate ab257782) was used. Wild-type and UFSP2 knockout samples were subjected to SDS-PAGE. ab185965 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at room temperature for 2.5 hours at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-UFSP2 antibody [EPR13424] (ab185965) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
UFSP2 knockout HEK293T cell lysate at 20 µg
Lane 2:
Western blot - Human UFSP2 knockout HEK-293T cell line (<a href='/products/cell-lines/human-ufsp2-knockout-hek-293t-cell-line-ab266368'>ab266368</a>)
Lane 3:
HeLa cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 53 kDa
Observed band size: 53 kDa
false
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
UFSP2 plays a significant role in the UFMylation pathway which is a post-translational modification process involving UFM1. This enzyme does not operate alone; it acts as part of a functional complex where its peptidase activity is essential for recycling UFM1 molecules after they detach from substrate proteins. The activation and deactivation of UFM1-modified proteins regulate several cellular processes such as protein translation cellular stress responses and maintenance of endoplasmic reticulum homeostasis.
Pathways
The UFSP2 protein contributes to the wider ubiquitin-like modification systems particularly impacting the protein quality control system and the endoplasmic reticulum-associated degradation (ERAD) pathway. It maintains protein folding and ensures degradation of misfolded proteins. UFSP2 interacts with other proteins such as UFL1 which acts as a specific E3 ligase for UFM1 establishing a cycle for efficient modification and de-modification in these pathways.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (5)
Recent publications for all applications. Explore the full list and refine your search
Science advances 9:eadh3635 PubMed37595036
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:350 PubMed37280198
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:7857 PubMed36543799
2022
Applications
Unspecified application
Species
Unspecified reactive species
Development (Cambridge, England) 146: PubMed30635284
2019
Applications
Unspecified application
Species
Unspecified reactive species
FEBS letters 591:196-204 PubMed27926783
2016
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com